Eris Biotech
Our drugs engage the immune system to fight tumors
What they do
Cancer patients with solid tumors face treatments that fail when tumors suppress the immune system.
The company develops small-molecule cancer therapeutics that inhibit immune suppression to activate the immune system against tumors.
Oncologists and healthcare providers treating patients with solid tumors such as mesothelioma.
Founders
PhD in Immunology from Dartmouth College. Engineered many novel cancer immunotherapies. We build cancer drugs that reawaken the immune system to fight cancer for you. No tox, no side effects, and most importantly -- no cancer.
PhD in microbiology and molecular biology with an emphasis in cancer immunology, working on developing drugs that reawaken the immune system to fight cancer. First-generation immigrant from Peru. Mom of two boys.
Company timeline
- Founded2023
- YC batchWinter 2024
- StatusActive
- Team size2 people
- LocationLehi, UT, USA
Similar startups
